Did you buy RARE common stock between August 3, 2023, and December 26, 2025? Affected Ultragenyx Pharmaceutical Inc. Investor Summary Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) What: Securities fraud class action lawsuit filed Class Period: August 3, 2023, through December 26,...
Hence then, the article about ultragenyx pharmaceutical inc rare investors april 6 2026 filing deadline in securities fraud class action contact kessler topaz meltzer check llp was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP )
Also on site :
- En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
- LA28 ticket registration nears deadline as first Olympic qualifiers emerge
- What do you need to vote in Illinois? What you can take into the ballot box with you